Thursday - November 21, 2024

Category Archives: Pharmaceuticals & Biotech

Treatment-Resistant Depression Treatment Market 2034: Clinical Trials, Medication, Prevalence, Incidence, Therapies, EMA, PDMA, FDA Approvals, and Companies by DelveInsight

Treatment-Resistant Depression Treatment Market Treatment-Resistant Depression companies working in the market are Navitor Pharmaceuticals, Supernus Pharmaceuti, Novartis, Relmada Therapeutics, Beckley Psytech, COMPASS Pathways, Axsome Therapeutics, Celon Pharma, and several others. (Albany, USA) DelveInsight’s “Treatment-Resistant Depression Market Insights, Epidemiology, and Market … Continue reading →

Non-Muscle Invasive Bladder Cancer Treatment Market 2034: Clinical Trials, Medication, Prevalence, Incidence, Therapies, EMA, PDMA, FDA Approvals, and Companies by DelveInsight

The non-muscle invasive bladder cancer market is predicted to surge owing to the launch of novel drugs by key companies such as UroGen Pharma, Pfizer, Roche, CG Oncology, ImmunityBio, Theralase, enGene, SURGE Therapeutics, and others, along with improved diagnosis during … Continue reading →

Periodontal Disease Market in the 7MM is expected to expand at a healthy growth rate by 2032, estimates DelveInsight

DelveInsight’s “Periodontal Disease Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Periodontal Disease, historical and forecasted epidemiology as well as the Periodontal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United … Continue reading →

Myopic Macular Degeneration Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Roche, Bayer, Regeneron Pharma

The Key Myopic Macular Degeneration Companies in the market include – Roche, Bayer, Regeneron Pharmaceuticals, and others.   DelveInsight’s “Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and … Continue reading →

Malignant Pleural Effusion Market Size in the 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight

DelveInsight’s “Malignant Pleural Effusion Market Insight, Epidemiology and Market Forecast – 2034” report delivers an in-depth analysis of malignant pleural effusion epidemiology, market, and clinical development understanding, Addition to this report provides historical and forecasted epidemiology and market data as well as … Continue reading →

Myocardial Infarction Market Expected to Experience Major Growth by 2034, According to DelveInsight | Pfizer, Novartis, AstraZeneca, Recardio, Idorsia Pharma, Eli Lilly and Company, Boehringer

The Key Myocardial Infarction Companies in the market include – Novartis, AstraZeneca, Recardio, Idorsia Pharmaceuticals, Eli Lilly and Company, Boehringer Ingelheim, Pfizer, Bayer, Mesoblast, Inc., The Medicines Company, Mitsubishi Tanabe Pharma, Athera Biotechnologies, Hoffmann-La Roche, and others.   DelveInsight’s “Myocardial … Continue reading →